May 19, 2018
Photocure Announces Blue Light Cystoscopy with Cysview Now Available for Surveillance of Bladder Cancer
Photocure ASA (OSE: PHO), May 16, 2018, announced today the launch of Blue Light Cystoscopy (BLC™) with Cysview for a new indication of surveillance cystoscopy of bladder cancer.
The new FDA approved indication was a result of a large Phase 3 study using blue light rigid and flexible cystoscopes from KARL STORZ Endoscopy of America Inc., which showed that BLC with Cysview significantly (p<0.0001) improves detection of patients with recurrent bladder cancer. Click here for the Prescribing